Tech Company Financing Transactions
Aqemia Funding Round
Aqemia closed a $30.2 million Series A funding round on 10/19/2022. Investors included Bpifrance, Eurazeo and Elaia Partners.
Transaction Overview
Company Name
Announced On
10/19/2022
Transaction Type
Venture Equity
Amount
$30,232,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to scale drug discovery and its proprietary therapeutic assets pipeline, with a first emphasis on oncology and immuno-oncology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Boulevard Pasteur
Paris, 75015
France
Paris, 75015
France
Phone
Undisclosed
Website
Email Address
Overview
Aqemia is a next-generation pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to scale the drug discovery process, by leveraging a unique-in-the world technology combining quantum-inspired physics and machine learning.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maximilien Levesque
Chief Operating Officer
Emmanuelle Martiano
Browse more venture capital transactions:
Prev: 10/19/2022: PIC Therapeutics venture capital transaction
Next: 10/19/2022: Otonomi venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs